Pituitary Carcinoma in a Patient with an SDHB Mutation
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2017/03/10
-
Journal
-
Indian UGC (journal)
-
Refrences35
-
Citations31
-
Nicola Tufton ORCID (unauthenticated)
-
Federico Roncaroli
-
Irene Hadjidemetriou
-
Mary N Dang
-
Judit Dénes
-
Leonardo Guasti
-
Maria Thom
-
Michael Powell
-
Stephanie E Baldeweg
-
Naomi Fersht
-
Márta Korbonits
Cite
Tufton, Nicola, et al. “Pituitary Carcinoma in a Patient With an SDHB Mutation”. Endocrine Pathology, vol. 28, no. 4, 2017, pp. 320-5, https://doi.org/10.1007/s12022-017-9474-7.
Tufton, N., Roncaroli, F., Hadjidemetriou, I., Dang, M. N., Dénes, J., Guasti, L., Thom, M., Powell, M., Baldeweg, S. E., Fersht, N., & Korbonits, M. (2017). Pituitary Carcinoma in a Patient with an SDHB Mutation. Endocrine Pathology, 28(4), 320-325. https://doi.org/10.1007/s12022-017-9474-7
Tufton N, Roncaroli F, Hadjidemetriou I, Dang MN, Dénes J, Guasti L, et al. Pituitary Carcinoma in a Patient with an SDHB Mutation. Endocrine Pathology. 2017;28(4):320-5.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the endocrine glands
Clinical endocrinology
Medicine
Internal medicine
Specialties of internal medicine
Nutritional diseases
Deficiency diseases
Medicine
Pathology
Science
Biology (General)
Science
Chemistry
Organic chemistry
Biochemistry
You May Also Like
- Precursors to Invasive Pancreatic Cancer
- Benign Fibro-Osseous Lesions: A Review of Current Concepts
- Columnar Cell Lesions of the Breast
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
- The 2019 WHO classification of tumours of the digestive system
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| 10.1074/jbc.M114.566356 | Journal of Biological Chemistry |
| 2015 | |
| Pituitary Adenoma With Paraganglioma/Pheochromocytoma (3PAs) and Succinate Dehydrogenase Defects in Humans and Mice | The Journal of Clinical Endocrinology & Metabolism |
| 95 | 2015 |
| Heterogeneous Genetic Background of the Association of Pheochromocytoma/Paraganglioma and Pituitary Adenoma: Results From a Large Patient Cohort | The Journal of Clinical Endocrinology & Metabolism |
| 108 | 2015 |
| The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas | Endocrine Pathology |
| 129 | 2015 |
| 10.1530/ERC-15-0241 | Endocrine-Related Cancer |
| 2015 |
Refrences Analysis
The category
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology 19
is the most frequently represented among the references in this article. It primarily includes studies from Clinical Endocrinology The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Genetic diagnosis in acromegaly and gigantism: From research to clinical practice | Best Practice & Research Clinical Endocrinology & Metabolism |
| 2024 | |
| Genetic Testing in Hereditary Pituitary Tumors | Archives of Medical Research |
| 1 | 2023 |
| Non-functioning pituitary carcinoma: Case report and literature review | International Journal of Surgery Case Reports |
| 2023 | |
Rare forms of hereditary endocrine neoplasia: co-existence of pituitary adenoma and pheochromocytoma/paraganglioma | Problems of Endocrinology |
| 2023 | |
An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma | Frontiers in Endocrinology |
| 2023 |
Citations Analysis
The category
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology 23
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled The emerging role and targetability of the TCA cycle in cancer metabolism and was published in 2017. The most recent citation comes from a 2024 study titled Genetic diagnosis in acromegaly and gigantism: From research to clinical practice. This article reached its peak citation in 2018, with 10 citations. It has been cited in 22 different journals, 13% of which are open access. Among related journals, the Endocrine-Related Cancer cited this research the most, with 5 citations. The chart below illustrates the annual citation trends for this article.